All News

What's annoying pharmacists this month?

Pharmacists should evaluate medications for potential problems at patient meetings to improve safety.

Prior research has associated early adolescent use of hormonal contraceptives with the risk of depression in adulthood.

Parties and get-togethers often present challenges for patients with allergies, particularly with home-cooked food that may have unclear ingredients.

Data to be presented at the 45th Annual San Antonio Breast Cancer Symposium suggest that the novel sequencing test can detect signs of disease recurrence across breast cancer subtypes, improving outcomes.

Treatment with immune checkpoint inhibitors have the potential for immune-related adverse events, such as psoriasis.

Students can begin learning about treating patients with trauma early.

Zanubrutinib expressed better cardiac safety measures, higher progression-free survival, and lower discontinuation rates in the ALPINE trial compared with compared ibrutinib.

Derazantinib is an investigational oral inhibitor of FGFR1, FGFR2, and FGFR3 in patients with locally advanced or metastatic intrahepatic cholangiocarcinoma.

Pharmacists can coordinate education programs for patients to normalize quality of life and minimize infusion-related pain.

On this month's list of Rx products is an FDA-updated label for a cardiovascular disease drug, 2 FDA-approved NDAs for schizophrenia and alopecia areata, and an FDA approved treatment for pustular psoriasis.

GSK3036656 demonstrates early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.

The implementation of negative control outcomes and a complementary cohort demonstrate an estimated beneficial effect that associated with an individual’s overall health.

Study suggests that high levels of nicotinamide riboside could increase the risk of developing triple-negative breast cancer and may cause the cancer to metastasize to the brain.

The trial data demonstrated that pembrolizumab in combination with chemotherapy also had statistically significant and clinically meaningful improvements in PFS and ORR as well.

Patients with lung cancer in an early-intervention lung screening program were found to have a survival rate nearly 20-times longer than patients with a late-stage diagnosis.

Patients with difficult-to-control hypertension have greater risk of heart attack, stroke, end-stage renal disease, and heart failure.

Instagram offers a myriad of ways to share content and connect with others.

Walgreens plans to focus on improving pharmacy staffing and retaining and rewarding current staff.

Study results show that patients with moderate or severe immune suppression should be considered a priority for additional vaccine doses and risk-reduction strategies.

This issue's OTC Cases answer common questions about a cough.

Pharmacists play a significant role in the comprehensive management of this condition through education, intervention, and monitoring.

Leveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.

Legislation expands protection of original 1965 act to individuals younger than 60 years.

Pharmacists should engage patients, explore system fixes to prevent missed drug-drug interactions

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.

The adeno-associated virus vector-based gene therapy is the first gene therapy to be approved by the FDA for hemophilia B.